GALNT15 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GJA3 | Gap junction protein, alpha 3, 46kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJA5 | Gap junction protein, alpha 5, 40kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GJB7 | Gap junction protein, beta 7, 25kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GLDN | Gliomedin | | | | | | Tissue enhanced |
GPR1 | G protein-coupled receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRAMD2 | GRAM domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
GYLTL1B | Glycosyltransferase-like 1B | Predicted secreted proteins
| | | | | Tissue enhanced |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
HIGD1B | HIG1 hypoxia inducible domain family, member 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
HLA-G | Major histocompatibility complex, class I, G | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HPGDS | Hematopoietic prostaglandin D synthase | Enzymes
| | | | | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HSPA6 | Heat shock 70kDa protein 6 (HSP70B') | Plasma proteins
| | | | | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
HYAL4 | Hyaluronoglucosaminidase 4 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
IGDCC3 | Immunoglobulin superfamily, DCC subclass, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
IGF2BP3 | Insulin-like growth factor 2 mRNA binding protein 3 | | | | | | Tissue enhanced |
IGFBP3 | Insulin-like growth factor binding protein 3 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IGSF5 | Immunoglobulin superfamily, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
IL12RB2 | Interleukin 12 receptor, beta 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
INHBA | Inhibin, beta A | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KANK4 | KN motif and ankyrin repeat domains 4 | | | | | | Tissue enhanced |
KRT81 | Keratin 81 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
LAIR2 | Leukocyte-associated immunoglobulin-like receptor 2 | CD markers Predicted secreted proteins
| | | | | Tissue enhanced |
LAMA2 | Laminin, alpha 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMC3 | Laminin, gamma 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LGR5 | Leucine-rich repeat containing G protein-coupled receptor 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
LGSN | Lengsin, lens protein with glutamine synthetase domain | | | | | | Tissue enhanced |
LINC01119 | Long intergenic non-protein coding RNA 1119 | | | | | | Tissue enhanced |
LYPD6 | LY6/PLAUR domain containing 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
MAP1LC3C | Microtubule-associated protein 1 light chain 3 gamma | | | | | | Tissue enhanced |
MBNL3 | Muscleblind-like splicing regulator 3 | | | | | | Tissue enhanced |
MEOX2 | Mesenchyme homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
METTL21C | Methyltransferase like 21C | | | | | | Tissue enhanced |
MFAP5 | Microfibrillar associated protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MKRN3 | Makorin ring finger protein 3 | Disease related genes
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MSMP | Microseminoprotein, prostate associated | | | | | | Tissue enhanced |
MSX2 | Msh homeobox 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
MYCN | V-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
NNAT | Neuronatin | Predicted membrane proteins
| | | | | Tissue enhanced |
NOG | Noggin | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
NRK | Nik related kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |